Liangwen Wang

490 total citations
8 papers, 373 citations indexed

About

Liangwen Wang is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Liangwen Wang has authored 8 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 3 papers in Molecular Biology and 2 papers in Surgery. Recurrent topics in Liangwen Wang's work include Pancreatic and Hepatic Oncology Research (2 papers), Gallbladder and Bile Duct Disorders (2 papers) and Innovative Microfluidic and Catalytic Techniques Innovation (1 paper). Liangwen Wang is often cited by papers focused on Pancreatic and Hepatic Oncology Research (2 papers), Gallbladder and Bile Duct Disorders (2 papers) and Innovative Microfluidic and Catalytic Techniques Innovation (1 paper). Liangwen Wang collaborates with scholars based in China, United States and Hong Kong. Liangwen Wang's co-authors include Gaoquan Gong, LI Guo-ping, Xiaolin Wang, Chenggang Wang, Yi Chen, Qiwen Ben, Tianzhu Yu, Yi Chen, Changyu Li and Minjie Yang and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Applied Materials & Interfaces and International Journal of Cancer.

In The Last Decade

Liangwen Wang

8 papers receiving 364 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liangwen Wang China 5 199 153 112 95 87 8 373
Roman Liebe Germany 11 260 1.3× 135 0.9× 192 1.7× 72 0.8× 73 0.8× 36 468
Yusuke Tsuchimoto Japan 10 153 0.8× 99 0.6× 87 0.8× 45 0.5× 62 0.7× 32 350
Massimiliano Balbi Italy 5 239 1.2× 290 1.9× 96 0.9× 147 1.5× 114 1.3× 10 452
Benyam D. Addissie United States 8 269 1.4× 77 0.5× 236 2.1× 60 0.6× 65 0.7× 13 472
Pei‐Wu Zhu China 13 383 1.9× 112 0.7× 172 1.5× 117 1.2× 20 0.2× 34 501
Yasushi Okura Japan 12 225 1.1× 104 0.7× 157 1.4× 82 0.9× 26 0.3× 28 394
Hong-Chuan Zhao China 9 96 0.5× 118 0.8× 53 0.5× 31 0.3× 60 0.7× 14 301
Tetsu Tomonari Japan 13 124 0.6× 91 0.6× 175 1.6× 30 0.3× 83 1.0× 38 374
Takuya Kuwashiro Japan 11 289 1.5× 92 0.6× 214 1.9× 85 0.9× 49 0.6× 22 485
Naotaka Shimozato Japan 13 177 0.9× 70 0.5× 158 1.4× 36 0.4× 26 0.3× 34 342

Countries citing papers authored by Liangwen Wang

Since Specialization
Citations

This map shows the geographic impact of Liangwen Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liangwen Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liangwen Wang more than expected).

Fields of papers citing papers by Liangwen Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liangwen Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liangwen Wang. The network helps show where Liangwen Wang may publish in the future.

Co-authorship network of co-authors of Liangwen Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Liangwen Wang. A scholar is included among the top collaborators of Liangwen Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liangwen Wang. Liangwen Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Hu, Wenqi, Hongwei� Jiang, Di Wu, et al.. (2024). DLM–GelMA/tumor slice sandwich structured tumor on a chip for drug efficacy testing. Lab on a Chip. 24(15). 3718–3727. 3 indexed citations
2.
Jiang, Hongwei, Jie Liu, Yuping Liu, et al.. (2023). Audible Acoustic Wave Promotes EV Formation and Secretion from Adherent Cancer Cells via Mechanical Stimulation. ACS Applied Materials & Interfaces. 15(46). 53859–53870. 4 indexed citations
3.
Zhang, Wen, Liangwen Wang, Minjie Yang, et al.. (2023). Effects of HepaSphere microsphere encapsule epirubicin with a new loading method transarterial chemoembolization: in vitro and in vivo experiments. Discover Oncology. 14(1). 209–209. 4 indexed citations
4.
Zhou, Yongjie, Liangwen Wang, Wen Zhang, et al.. (2022). Identification of Epithelial Mesenchymal Transition-Related lncRNAs Associated with Prognosis and Tumor Immune Microenvironment of Hepatocellular Carcinoma. Disease Markers. 2022. 1–17. 3 indexed citations
5.
Yu, Tianzhu, Wei Zhang, Changyu Li, et al.. (2020). Percutaneous intraductal radiofrequency ablation combined with biliary stent placement for treatment of malignant biliary obstruction. Abdominal Radiology. 45(11). 3690–3697. 11 indexed citations
6.
Li, Junhao, Tianzhu Yu, Li Zhang, et al.. (2020). An iodine-125 seed strand combined with a metal stent versus a metal stent alone for obstructive jaundice caused by pancreatic ductal adenocarcinoma. Brachytherapy. 20(2). 446–453. 4 indexed citations
7.
Cheng, Jiemin, et al.. (2018). Precise localization of small pulmonary nodules using Pre-VATS with Xper-CT in combination with real-time fluoroscopy-guided coil: report of 15 patients.. SHILAP Revista de lepidopterología. 1(2). 102–105. 1 indexed citations
8.
Wang, Chenggang, Xiaolin Wang, Gaoquan Gong, et al.. (2011). Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: A systematic review and meta‐analysis of cohort studies. International Journal of Cancer. 130(7). 1639–1648. 343 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026